Multimedia

Clement Chung, PharmD, MS, BCOP, BCPS, senior clinical pharmacy specialist, hematology and oncology, Houston Methodist West Hospital, reviews the landscape of small molecule inhibitors for chronic lymphocytic leukemia, including important...

Russell Spjut, PharmD, director, formulary management, Magellan Rx Management, shares insight on the regulatory pathways for emerging PDTs, and discusses some of the work of the Digital Therapeutic Alliance.

Cheryl Dalton-Norman, MBA, BSN, RN, president and cofounder, Conduit Health Partners, comments on how the combination of RSV, COVID-19, and flu impacted health systems, as well as how organizations can optimize their workflows to meet surges...

John RP Tesser, MD, rheumatology specialist, Arizona Arthritis & Rheumatology Associates, and clinical adjunct professor, Midwestern University College of Health Sciences, discusses the MIRROR trial, a study which showed the addition of an...

Craig Gravina, chief technology officer, ObvioHealth, sheds some light on the current digital therapeutics landscape, including regulatory challenges, the prescription DTx model, and solutions to improve clinical trial research.

Gary Owens, MD, discusses how payers might develop formularies for prescription digital therapeutics, as well as what metrics may be used to determine their efficacy.

Marcelo Bigal, MD, PhD, chief executive officer, Ventus Therapeutics, discusses a drug discovery platform called ReSOLVE and speaks broadly about how innovations in technology can facilitate faster, more efficient drug development.

Colin Banas, MD, MHA, chief medical officer, DrFirst, reviews survey findings which suggest a significant portion of patients abandon prescriptions due to cost, and shares how price transparency tools can inform and improve prescribing...